Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
featured
A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

  • 134 views
  • 08 Nov, 2020
  • 1 location
featured
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

  • 152 views
  • 08 Nov, 2020
  • 1 location
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial

the treatment of trigeminal neuralgia. Carbamazepine and oxcarbazepine are the first-choice drugs for the treatment of TN. Other drugs include lamotrigine , baclofen , gabapentin, antidepressants

ache
carbamazepine
oxcarbazepine
facial pain
  • 9 views
  • 26 Sep, 2021
  • 2 locations
Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy

treatment, use of standing devices and spasticity treatments (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental sitting is expected to reduce the MP change compared

  • 0 views
  • 26 Jan, 2021
  • 1 location
Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder

patients during their first year of baclofen prescription for alcohol use disorder. The main objective of the study is to determine the rate of patients who stop baclofen due to an adverse event (AE

psychotropic drugs
baclofen
  • 11 views
  • 24 Jan, 2021
  • 19 locations
Baclofen in Managing Acute Alcohol Withdrawal

The study goal is to investigate whether administration of oral baclofen forms an adequate treatment option in the management of acute alcohol withdrawal. The investigators will compare placebo

alcohol withdrawal syndrome
acute alcohol withdrawal
baclofen
  • 10 views
  • 26 Jan, 2021
  • 1 location
Baclofen as a Perioperative Analgesic Adjuvant

The purpose of this study is to determine whether a single, oral dose of baclofen alters postoperative opioid requirements.

opioid
analgesics
  • 6 views
  • 26 Sep, 2021
  • 1 location
Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers

To determine if baclofen will enhance buprenorphine analgesia for acute pain in healthy volunteers.

analgesia
acute pain
buprenorphine
pain relieving
  • 11 views
  • 04 Jun, 2021
  • 1 location
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)

Comparing the efficacy of Intracthecal Baclofen dose between the Prometra II and Medtronic SynchroMed II for patients with spasticity and with current a current SyncroMed II pump needing

spasticity
baclofen
  • 0 views
  • 26 Jan, 2021
  • 1 location
Effectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder

more attractive. To date, nalmefen is the only treatment marketed for this indication. Baclofen should be marketed in 2020, but with restrictive prescription criteria. In this new strategy to

  • 0 views
  • 14 Mar, 2021
  • 1 location